With your help, target pediatric aml can...
Jumpstart personalized, precision medicine for young AML patients
Create a fundamental shift in how AML is diagnosed, monitored and treated
comprehensively identify the vulnerabilities
of pediatric AML through collaboration
TOGETHER, We can overcome pediatric aml.
Accelerating the “highest potential, greatest-need”, strategic research project can fundamentally change how AML is treated in young patients ages 0-35.
Did you know?
The vast majority of all AML funding goes to The adult form
Pediatric AML is categorically different
- A majority of treatments were tested and designed for adult patients with AML, and are passed down to kids.
- Kids and teens fighting AML often find themselves at the “end of the line” waiting for new, “hand-me-down” therapies designed for older adults.
- Targeted, personalized treatments are incredibly promising, yet lack necessary funding.